
IRadimed Corp
NASDAQ:IRMD

Intrinsic Value
The intrinsic value of one
IRMD
stock under the Base Case scenario is
33.12
USD.
Compared to the current market price of 51.66 USD,
IRadimed Corp
is
Overvalued by 36%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
IRadimed Corp
Fundamental Analysis


Revenue & Expenses Breakdown
IRadimed Corp
Balance Sheet Decomposition
IRadimed Corp
Current Assets | 75.1m |
Cash & Short-Term Investments | 50.3m |
Receivables | 12.7m |
Other Current Assets | 12.1m |
Non-Current Assets | 26.6m |
PP&E | 20.4m |
Intangibles | 3.3m |
Other Non-Current Assets | 2.9m |
Free Cash Flow Analysis
IRadimed Corp
USD | |
Free Cash Flow | USD |
Earnings Waterfall
IRadimed Corp
Revenue
|
75.2m
USD
|
Cost of Revenue
|
-17.3m
USD
|
Gross Profit
|
57.8m
USD
|
Operating Expenses
|
-35.2m
USD
|
Operating Income
|
22.6m
USD
|
Other Expenses
|
-2.9m
USD
|
Net Income
|
19.8m
USD
|
IRMD Profitability Score
Profitability Due Diligence
IRadimed Corp's profitability score is 73/100. The higher the profitability score, the more profitable the company is.

Score
IRadimed Corp's profitability score is 73/100. The higher the profitability score, the more profitable the company is.
IRMD Solvency Score
Solvency Due Diligence
IRadimed Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Score
IRadimed Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IRMD Price Targets Summary
IRadimed Corp
According to Wall Street analysts, the average 1-year price target for
IRMD
is 72.42 USD
with a low forecast of 70.7 USD and a high forecast of 75.6 USD.
Dividends
Current shareholder yield for IRMD is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
IRMD
stock under the Base Case scenario is
33.12
USD.
Compared to the current market price of 51.66 USD,
IRadimed Corp
is
Overvalued by 36%.